OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immune checkpoint inhibitors plus platinum-based chemotherapy compared to platinum-based chemotherapy with or without bevacizumab for first-line treatment of older people with advanced non-small cell lung cancer
Émeline Orillard, Arjab Adhikari, Reem Malouf, et al.
Cochrane library (2024) Vol. 2024, Iss. 8
Closed Access | Times Cited: 5
Émeline Orillard, Arjab Adhikari, Reem Malouf, et al.
Cochrane library (2024) Vol. 2024, Iss. 8
Closed Access | Times Cited: 5
Showing 5 citing articles:
Energy Metabolism and Stemness and the Role of Lauric Acid in Reversing 5-Fluorouracil Resistance in Colorectal Cancer Cells
Rina Fujiwara‐Tani, Yi Luo, Ruiko Ogata, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 664-664
Open Access | Times Cited: 1
Rina Fujiwara‐Tani, Yi Luo, Ruiko Ogata, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 664-664
Open Access | Times Cited: 1
Immunotherapy for Elderly Patients with Advanced Non-Small Cell Lung Cancer: Challenges and Perspectives
Anass Baladi, Hassan Abdelilah Tafenzi, Othmane Zouiten, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2120-2120
Open Access | Times Cited: 1
Anass Baladi, Hassan Abdelilah Tafenzi, Othmane Zouiten, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2120-2120
Open Access | Times Cited: 1
Efficacy and safety of immune checkpoint inhibitors in elderly patients with advanced non-small cell lung cancer: a systematic review and meta-analysis
Jiacheng Yao, Sihan Li, Lu Bai, et al.
EClinicalMedicine (2025) Vol. 81, pp. 103081-103081
Closed Access
Jiacheng Yao, Sihan Li, Lu Bai, et al.
EClinicalMedicine (2025) Vol. 81, pp. 103081-103081
Closed Access
How does the addition of immune checkpoint inhibitors (ICIs) to platinum-based chemotherapy compare with platinum-based chemotherapy alone as a first-line treatment for older adults with non-small cell lung cancer (NSCLC)?
Amin Sharifan
Cochrane Clinical Answers (2025)
Closed Access
Amin Sharifan
Cochrane Clinical Answers (2025)
Closed Access
Targeted and cytotoxic inhibitors used in the treatment of lung cancers
Robert Roskoski
Pharmacological Research (2024), pp. 107465-107465
Open Access | Times Cited: 3
Robert Roskoski
Pharmacological Research (2024), pp. 107465-107465
Open Access | Times Cited: 3
